{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:14:55Z","timestamp":1789186495940,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-021-01346-4","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T09:02:51Z","timestamp":1637744571000},"page":"1085-1091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Anti-Tr\/DNER Antibody\u2013Associated Cerebellar Ataxia: a Systematic Review"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-0130","authenticated-orcid":false,"given":"Igor Gusm\u00e3o","family":"Campana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Diogo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"issue":"4","key":"1346_CR1","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","volume":"8","author":"F Graus","year":"2021","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, Antoine J-CG, Desestret V, Dubey D, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1014. Available from. https:\/\/doi.org\/10.1212\/NXI.0000000000001014.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"1346_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s12311-020-01132-8","volume":"19","author":"M Hadjivassiliou","year":"2020","unstructured":"Hadjivassiliou M, Graus F, Honnorat J, Jarius S, Titulaer M, Manto M, et al. Diagnostic criteria for primary autoimmune cerebellar ataxia-guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias. Cerebellum. 2020;19(4):605\u201310.","journal-title":"Cerebellum."},{"key":"1346_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12974-015-0358-9","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B. \u201cMedusa head ataxia\u201d: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo\/CDR2, anti-Nb\/AP3B2, PCA-2, anti-Tr\/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation. 2015;12:168.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"1346_CR4","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/archneur.1976.00500090066014","volume":"33","author":"JL Trotter","year":"1976","unstructured":"Trotter JL, Hendin BA, Osterland CK. Cerebellar degeneration with Hodgkin disease. An immunological study. Arch Neurol. 1976;33(9):660\u20131.","journal-title":"Arch Neurol"},{"issue":"6","key":"1346_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.23550","volume":"71","author":"E de Graaff","year":"2012","unstructured":"de Graaff E, Maat P, Hulsenboom E, van den Berg R, van den Bent M, Demmers J, et al. Identification of delta\/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2012;71(6):815\u201324.","journal-title":"Ann Neurol"},{"key":"1346_CR6","doi-asserted-by":"publisher","unstructured":"Arya S, Kaji AH, Boermeester MA. PRISMA reporting guidelines for meta-analyses and systematic reviews. JAMA Surg. 2021; Available from. https:\/\/doi.org\/10.1001\/jamasurg.2021.0546.","DOI":"10.1001\/jamasurg.2021.0546"},{"issue":"1","key":"1346_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40673-021-00137-1","volume":"8","author":"PB Christensen","year":"2021","unstructured":"Christensen PB, Gregersen H, Almasi C. Anti-Tr\/DNER antibody paraneoplastic cerebellar degeneration preceding a very late relapse of Hodgkin Lymphoma after 12 years. Cerebellum Ataxias. 2021;8(1):14.","journal-title":"Cerebellum Ataxias"},{"issue":"1","key":"1346_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1744-9987.2006.00348.x","volume":"10","author":"Y Taniguchi","year":"2006","unstructured":"Taniguchi Y, Tanji C, Kawai T, Saito H, Marubayashi S, Yorioka N. A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody. Ther Apher Dial. 2006;10(1):90\u20133.","journal-title":"Ther Apher Dial"},{"issue":"3","key":"1346_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00381-016-3284-y","volume":"33","author":"S Gungor","year":"2017","unstructured":"Gungor S, Kilic B, Arslan M, Ozgen U, Dalmau J. Hodgkin\u2019s lymphoma associated with paraneoplastic cerebellar degeneration in children: a case report and review of the literature. Childs Nerv Syst. 2017;33(3):509\u201312.","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"1346_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4103\/0972-2327.99720","volume":"15","author":"V Suri","year":"2012","unstructured":"Suri V, Khan NI, Jadhao N, Gupta R. Paraneoplastic cerebellar degeneration in Hodgkin\u2019s lymphoma. Ann Indian Acad Neurol. 2012l;15(3):205\u20137.","journal-title":"Ann Indian Acad Neurol"},{"issue":"Pt 6","key":"1346_CR11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/brain\/awg133","volume":"126","author":"S Shams\u2019ili","year":"2003","unstructured":"Shams\u2019ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 2003;126(Pt 6):1409\u201318.","journal-title":"Brain."},{"issue":"7","key":"1346_CR12","first-page":"243","volume":"64","author":"PF Ypma","year":"2006","unstructured":"Ypma PF, Wijermans PW, Koppen H, Sillevis Smitt PAE. Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin\u2019s lymphoma. Neth J Med. 2006 Jul;64(7):243\u20137.","journal-title":"Neth J Med"},{"issue":"4","key":"1346_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.clineuro.2005.01.008","volume":"108","author":"K Bruylant","year":"2006","unstructured":"Bruylant K, Crols R, Humbel RL, Appel B, De Deyn PP. Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung. Clin Neurol Neurosurg. 2006;108(4):415\u20137.","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"1346_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1600-0404.1998.tb01748.x","volume":"98","author":"J Peltola","year":"1998","unstructured":"Peltola J, Hietaharju A, Rantala I, Lehtinen T, Haapasalo H. A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin\u2019s disease. Acta Neurol Scand. 1998;98(5):360\u20133.","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"1346_CR15","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamaneurol.2014.999","volume":"71","author":"M Greene","year":"2014","unstructured":"Greene M, Lai Y, Baella N, Dalmau J, Lancaster E. Antibodies to Delta\/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma. JAMA Neurol. 2014;71(8):1003\u20138.","journal-title":"JAMA Neurol"},{"issue":"2","key":"1346_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1212\/01.WNL.0000041495.87539.98","volume":"60","author":"F Bernal","year":"2003","unstructured":"Bernal F, Shams\u2019ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin\u2019s disease. Neurology. 2003;60(2):230\u20134.","journal-title":"Neurology."},{"issue":"1\u20132","key":"1346_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0165-5728(96)00205-6","volume":"74","author":"F Graus","year":"1997","unstructured":"Graus F, Dalmau J, Valldeoriola F, Ferrer I, Re\u00f1e R, Marin C, et al. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin\u2019s disease. J Neuroimmunol. 1997;74(1\u20132):55\u201361.","journal-title":"J Neuroimmunol"},{"issue":"9","key":"1346_CR18","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1080\/10428190600678082","volume":"47","author":"A Geromin","year":"2006","unstructured":"Geromin A, Candoni A, Marcon G, Ferrari S, Sperotto A, De Luca S, et al. Paraneoplastic cerebellar degeneration associated with anti-neuronal anti-Tr antibodies in a patient with Hodgkin\u2019s disease. Leuk Lymphoma. 2006;47(9):1960\u20133.","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"1346_CR19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/00207454.2017.1412967","volume":"128","author":"P Schwenkenbecher","year":"2018","unstructured":"Schwenkenbecher P, Chacko L, Pul R, S\u00fchs K-W, Wegner F, Wurster U, et al. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells. Int J Neurosci. 2018;128(8):721\u20138.","journal-title":"Int J Neurosci"},{"issue":"8","key":"1346_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1212\/WNL.0b013e31820d62eb","volume":"76","author":"C Briani","year":"2011","unstructured":"Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology. 2011;76(8):705\u201310.","journal-title":"Neurology."},{"key":"1346_CR21","unstructured":"Quero K, Joubert B, Picard G, Rogemont V, Touati M, Jaccard A, Magi L, Abraham J, Honnorat J. Paraneoplastic cerebellar degeneration associated with Hodgkin lymphoma: a French retrospective cohort. Poster presented at: 25th Congress of the European Hematology Association. June 11\u201321, 2020."},{"key":"1346_CR22","doi-asserted-by":"crossref","unstructured":"Barba C, Alexopoulos H, Dimitriadou M, Akrivou S, Tsiortou P, Plomaritoglou A, Dalakas MC. Anti- Trantibodies in autoimmune cerebellar ataxia: Serial antibody testing and response to immunotherapy (P2.2-039). Neurology. 2019; 92(15 Supplement).\u00a0https:\/\/n.neurology.org\/content\/92\/15_Supplement\/P2.2-039.abstract.","DOI":"10.1212\/WNL.92.15_supplement.P2.2-039"},{"key":"1346_CR23","doi-asserted-by":"publisher","first-page":"725219","DOI":"10.1155\/2011\/725219","volume":"2011","author":"P Shenoy","year":"2011","unstructured":"Shenoy P, Maggioncalda A, Malik N, Flowers CR. Incidence patterns and outcomes for Hodgkin lymphoma patients in the United States. Adv Hematol. 2011;2011:725219.","journal-title":"Adv Hematol"},{"issue":"2","key":"1346_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.mcn.2005.10.003","volume":"31","author":"A Tohgo","year":"2006","unstructured":"Tohgo A, Eiraku M, Miyazaki T, Miura E, Kawaguchi S-Y, Nishi M, et al. Impaired cerebellar functions in mutant mice lacking DNER. Mol Cell Neurosci. 2006;31(2):326\u201333.","journal-title":"Mol Cell Neurosci"},{"issue":"23","key":"1346_CR25","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1200\/JCO.2006.07.0482","volume":"25","author":"A Engert","year":"2007","unstructured":"Engert A, Franklin J, Eich HT, Brillant C, Sehlen S, Cartoni C, et al. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin\u2019s lymphoma: final results of the GHSG HD7 trial. J Clin Oncol. 2007;25(23):3495\u2013502.","journal-title":"J Clin Oncol"},{"issue":"19","key":"1346_CR26","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1056\/NEJMoa064601","volume":"357","author":"C Ferm\u00e9","year":"2007","unstructured":"Ferm\u00e9 C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, et al. Chemotherapy plus involved-field radiation in early-stage Hodgkin\u2019s disease. N Engl J Med. 2007;357(19):1916\u201327.","journal-title":"N Engl J Med"},{"issue":"6","key":"1346_CR27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1200\/JCO.2012.43.4803","volume":"31","author":"LI Gordon","year":"2013","unstructured":"Gordon LI, Hong F, Fisher RI, Bartlett NL, Connors JM, Gascoyne RD, et al. Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496). J Clin Oncol. 2013;31(6):684\u201391.","journal-title":"J Clin Oncol"},{"key":"1346_CR28","doi-asserted-by":"publisher","first-page":"630602","DOI":"10.1155\/2013\/630602","volume":"2013","author":"MP Zaborowski","year":"2013","unstructured":"Zaborowski MP, Michalak S. Cell-mediated immune responses in paraneoplastic neurological syndromes. Clin Dev Immunol. 2013;2013:630602.","journal-title":"Clin Dev Immunol"},{"issue":"28","key":"1346_CR29","doi-asserted-by":"publisher","first-page":"25400","DOI":"10.1074\/jbc.M110793200","volume":"277","author":"M Eiraku","year":"2002","unstructured":"Eiraku M, Hirata Y, Takeshima H, Hirano T, Kengaku M. Delta\/Notch-like epidermal growth factor (EGF)-related receptor, a novel EGF-like repeat-containing protein targeted to dendrites of developing and adult central nervous system neurons *. J Biol Chem. 2002;277(28):25400\u20137.","journal-title":"J Biol Chem"},{"key":"1346_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archneur.1963.00460100095011","volume":"9","author":"NB Rewcastle","year":"1963","unstructured":"Rewcastle NB. Subacute cerebellar degeneration with Hodgkin\u2019s disease. Arch Neurol. 1963;9:407\u201313.","journal-title":"Arch Neurol"},{"issue":"1","key":"1346_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/jnnp.29.1.45","volume":"29","author":"L Horwich","year":"1966","unstructured":"Horwich L, Buxton PH, Ryan GM. Cerebellar degeneration with Hodgkin\u2019s disease. J Neurol Neurosurg Psychiatry. 1966;29(1):45\u201351.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1346_CR32","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","DOI":"10.1136\/bmj.39489.470347.AD"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-021-01346-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-021-01346-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-021-01346-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T19:07:49Z","timestamp":1726168069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-021-01346-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1346"],"URL":"https:\/\/doi.org\/10.1007\/s12311-021-01346-4","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"assertion":[{"value":"12 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}